Proof-of-reserve online · Robinhood
Apothecary of on-chain science

The shelf
is open.

We broke the pharma lock. Royalties from patents, biobanks & clinical trials — fractionalized into vials anyone can hold. Real assets, real yield, on-chain.

1,284 compounds shelved 18 institutions verified $248.6M elixir reserve ERC-3643 permissioned RWA Epoch 417
Compounds on shelf
1,284
across 18 institutions
Blended dosage
11.7% APY
▲ 0.6% · streamed in USDC
Purity index
86.4
backing 40 · oracle 25 · review 20 · risk 15
Research financed
$61.4M
73 prescriptions · $709K royalty / epoch

The Shelf

RWA-backed · mark-to-market · oracle attested

Open Prescriptions

Milestone escrow · funds release per read-out
RX-PRESALE

Antifibrotic Small Molecule

Karolinska Institutet · verified
IP-NFT
Committed$4.2M / $6.0M
IND ✓Ph1 ✓Ph2NDA
Dosage 13–16%Patent + royalty
Escrow releases $1.5M on Ph2 read-out · Chainlink DON
Fill Prescription
RX-INFRA

Automated Sequencing Lab

DeSci Labs SG · verified
Infra
Committed$2.8M / $3.5M
Procure ✓Install ✓Uptime SLA
Dosage 7–9%Equipment + lease
Releases on 30-day uptime attestation · oracle
Fill Prescription
RX-DATA

Rare-Disease Registry

Genomics Commons · verified
Data
Committed$0.9M / $2.0M
Consent ✓IngestZK proofAPI
Dosage 18–24%API metering
ZK-gated: pays on verified data ingest · no PII on-chain
Fill Prescription

DeSci Wire

Live from the decentralized-science ecosystem · external sources
crypto.news · Jun 2026

Bio Protocol launches OpenLabs to challenge grant gatekeepers

Unveiled at DeSci Berlin 2026, OpenLabs fuses AI-assisted research, community funding and on-chain governance as Bio's ecosystem surpasses $33M raised via BIO Genesis.

Read at crypto.news
The Block · Sep 2025

Bio Protocol raises $6.9M led by Arthur Hayes' Maelstrom Fund

Seed round joined by Mechanism Capital and Animoca Brands. First BioAgent "Aubrai" — built with VitaDAO — minted 1,000+ hypotheses on-chain; its token ran 150x.

Read at The Block
Bio Protocol · Bio V2

An AI-native platform for decentralized science

Bio V2 introduces on-chain fundraising, staking and agentic AI. Since 2024 the network has directed $50M+ to labs worldwide, an alternative amid global funding cuts.

Read at bio.xyz
Berkeley CMR · Nov 2025

Can Decentralized Science Be the Next Frontier of Research?

Over 50 active DeSci projects worldwide have now attracted $60M+ in combined institutional and community funding, using community ownership to bypass grant bottlenecks.

Read at Berkeley
Partners in Digital Health · 2026

DeSci & the future of health research

"2026 will see DeSci become much more than a perceived niche." A look at maturing DAO governance, IP-NFT enforceability and the compliance rails coming next.

Read the essay
VitaDAO · blog

VitaDAO awarded 21M BIO tokens for pioneering DeSci

Granted through Bio Protocol's bio/acc rewards program, the allocation lets VitaDAO govern curation, funding and liquidity across the broader bioDAO ecosystem.

Read at VitaDAO